Bioxyne Limited (ASX:BXN)

Market Cap	168.02M +223.4%
Revenue (ttm)	47.95M +178.2%
Net Income	8.97M +300.8%
EPS	0.00 +259.9%
Shares Out	2.27B
PE Ratio	18.65
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,485,123
Average Volume	4,187,914
Open	0.0780
Previous Close	0.0760
Day's Range	0.0710 - 0.0780
52-Week Range	0.0200 - 0.0800
Beta	0.63
RSI	66.35
Earnings Date	Feb 25, 2026

About Bioxyne

Bioxyne Limited, together with its subsidiaries, manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan. It operates through Pharmaceutical Manufacture and Wholesale Supply of Novel Medicines, Cannabis, Psilocybin, and MDMA; Manufacture and Distribution (Wholesale, Online, and Retail) of Consumer Health and Novel Food Products; and Wholesale of Patented Probiotics segments. The company offers active pharmaceutical ingr...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1998
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: BXN